Secondary Prevention in Younger vs. Older Coronary Heart Disease Patients—Insights from the German Subset of the EUROASPIRE IV Survey-Reference-Cited by-同舟云学术

Secondary Prevention in Younger vs. Older Coronary Heart Disease Patients—Insights from the German Subset of the EUROASPIRE IV Survey

Published:2017-10-30 Issue:3 Volume:25 Page:283-293
ISSN:1070-5503
Container-title:International Journal of Behavioral Medicine
language:en
Short-container-title:Int.J. Behav. Med.

Author:

Wagner Martin^ORCID,Gelbrich Götz,Kircher Julia,Kotseva Kornelia,Wood David,Morbach Caroline,Leyh Rainer,Ertl Georg,Karmann Wolfgang,Störk Stefan,Heuschmann Peter U.

Funder

Bundesministerium für Bildung und Forschung

Publisher

Springer Science and Business Media LLC

Subject

Applied Psychology

Link

http://link.springer.com/article/10.1007/s12529-017-9691-y/fulltext.html

Reference51 articles.

1. Members TF, Montalescot G, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003. https://doi.org/10.1093/eurheartj/eht296 .

2. Kotseva K, Wood D, De Backer G, et al. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009;373(9667):929–40. https://doi.org/10.1016/S0140-6736(09)60330-5 .

3. Kotseva K, Wood D, De Bacquer D, et al. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2015; https://doi.org/10.1177/2047487315569401 .

4. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events. Eur Heart J. 1997;18(10):1569–82.

5. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J. 2001;22(7):554–72. https://doi.org/10.1053/euhj.2001.2610 .

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors, clinical features, and outcomes of premature acute myocardial infarction;Frontiers in Cardiovascular Medicine;2022-11-30

2. Secondary prevention in diabetic and nondiabetic coronary heart disease patients: Insights from the German subset of the hospital arm of the EUROASPIRE IV and V surveys;Clinical Research in Cardiology;2022-09-27

3. Patient-reported continuity of care and the association with patient experience of cardiovascular prevention: an observational study in Germany;BMC Primary Care;2022-07-18

4. Case Challenge: Nulliparous Cardiac Challenges: A Diagnostic Case;The Journal for Nurse Practitioners;2021-12

5. Functional versus morphological assessment of vascular age in patients with coronary heart disease;Scientific Reports;2021-09-13